|

Dexmedetomidine vs Midazolam in Coronary Artery By-pass Surgery

RECRUITINGN/ASponsored by Cumhuriyet University
Actively Recruiting
PhaseN/A
SponsorCumhuriyet University
Started2026-01-15
Est. completion2026-06-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07411794

Summary

The aim is to compare the incidence of postoperative delirium following coronary artery bypass grafting (CABG) between patients receiving dexmedetomidine and those receiving midazolam infusions.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adult patients scheduled for elective coronary artery bypass graft surgery.

Exclusion Criteria:

* Patients with renal disorders,
* Patients with hepatic disorders,
* Patients with neuropsychiatric disorders,
* Patients whom informed consent could not be obtained
* Patients who declined to participate in the study.

Conditions2

Heart DiseasePostoperative Delirium

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.